The invention relates to compounds corresponding to formula (I):Rrepresents a group -SO2-NR3R4, a hydrogen atom, a halogen atom, a group -halo (C1-C5)alkyl, a group -CO2R5 or a group -SO2-R4；Rlrepresents a heterocycloalkyl group not containing a nitrogen atom, a group -W-(C3-C6)cycloalkyl, a group -W-aryl, a group -W-heteroaryl, a group -W-heterocycloalkyl, a group -W-COOR5, a group -W-CONR5R6；R2represents a hydrogen atom, a group -(C1-C5)alkyl, a group -(C1 -C5)alkylene-O-(C1-C5)alkyl, a group -halo(C1-C5)alkyl, a group -W-COOR5, a group -W-C(O)NHR5 or a group -W-C(O)-NR5R6；nrepresents 0, 1 or 2；Wis a group -(C1-C5)alkylene- or a group -(C3-C6)cycloalkylene-；R3andR4, which may be identical or different, represent, independently of each other, a hydrogen atom, a group -(C1-C5)alkyl, a group -(C3-C6)cycloalkyl, a group -(C1-C5)alkylene-O-(C1-C5)alkyl, an aryl, a group -CH2-aryl, a heteroaryl, a heterocycloalkyl, a group -W-OH, a group -W-CHOH-CH2OH, a group -W-CO2R5, a group -W-NR5R6 or a group -W-O-(CH2)n-aryl； or alternativelyR3andR4form, together with the nitrogen atom that bears them, a heterocycloalkyl group；R5andR6,which may be identical or different, represent, independently of each other, a hydrogen atom, a group -(C1-C5)alkyl or a group -(C1-C5)haloalkyl, and also to a process for preparing them and to their therapeutic uses.本發明係關於一種對應於式(I)之化合物，R表示基團-SO2-NR3R4、氫原子、鹵素原子、基團-鹵基(C1-C5)烷基、基團-CO2R5或基團-SO2-R4；R1表示不含氮原子之雜環烷基、基團-W-(C3-C6)環烷基、基團-W-芳基、基團-W-雜芳基、基團-W-雜環烷基、基團-W-COOR5、基團-W-CONR5R6；R2表示氫原子、基團-(C1-C5)烷基、基團-(C1-C5)伸烷基-O-(C1-C5)烷基、基團-鹵基(C1-C5)烷基、基團-W-COOR5、基團-W-C(O)NHR5或基團-W-C(O)-NR5R6；n表示0、1或2；W為基團-(C1-C5)伸烷基-或基團-(C3-C6)伸環烷基-；R3及R4可相同或不同，彼此獨立地表示氫原子、基團-(C1-C5)烷基、基團-(C3-C6)環烷基、基團-(C1-C5)伸烷基-O-(C1-C5)烷基、芳基、基團-CH2-芳基、雜芳基、雜環烷基、基團-W-OH、基團-W-CHOH-CH2OH、基團-W-CO2R5、基團-W-NR5R6或基團-W-O-(CH2)n-芳基；或者R3及R4與承載其之氮原子共同形成雜環烷基；R5及R6可相同或不同，彼此獨立地表示氫原子、基團-(C1-C5)烷基或基團-(C1-C5)鹵烷基，且亦係關於其製備方法及其治療用途。
